Drug Shrinks Belly Fat in HIV Patients
Unknown Title
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A drug called tesamorelin helps HIV patients with big bellies lose belly fat without losing fat from arms or legs. It works best if taken for a long time. When stopped, the fat comes back. People felt better about their bodies, and doctors saw improvements too. The drug doesn’t hurt blood sugar.
Surprising Findings
Tesamorelin reduces visceral fat without altering subcutaneous fat or limb fat.
Most fat-loss interventions (diet, exercise, other drugs) reduce fat everywhere. This drug is like a sniper—only hitting the fat deep inside the abdomen, leaving everything else untouched.
Practical Takeaways
HIV patients with abdominal fat buildup should discuss tesamorelin with their doctor if they’re struggling with body image or metabolic risk.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A drug called tesamorelin helps HIV patients with big bellies lose belly fat without losing fat from arms or legs. It works best if taken for a long time. When stopped, the fat comes back. People felt better about their bodies, and doctors saw improvements too. The drug doesn’t hurt blood sugar.
Surprising Findings
Tesamorelin reduces visceral fat without altering subcutaneous fat or limb fat.
Most fat-loss interventions (diet, exercise, other drugs) reduce fat everywhere. This drug is like a sniper—only hitting the fat deep inside the abdomen, leaving everything else untouched.
Practical Takeaways
HIV patients with abdominal fat buildup should discuss tesamorelin with their doctor if they’re struggling with body image or metabolic risk.
Publication
Related Content
Claims (10)
Continuing tesamorelin for a full year helps HIV patients with belly fat lose nearly 18% of their dangerous internal belly fat, with no loss of benefit over time.
Doctors see noticeable improvements in the belly shape of HIV patients taking tesamorelin, while those on a dummy pill show no change.
HIV patients with belly fat buildup feel better about their appearance after taking tesamorelin, while those on a dummy pill don't notice a difference.
In a 12-month randomized, double-blind, placebo-controlled trial, continued tesamorelin treatment led to an 18% reduction in visceral adipose tissue, while discontinuation resulted in rapid fat regain, demonstrating a direct and reversible cause-and-effect relationship.
If HIV patients stop taking the injection, the belly fat they lost comes right back quickly.